Lourival Possani

Title: Lourival Possani: Innovator in Platelet Aggregation Inhibition

Introduction

Lourival Possani is a notable inventor based in Cuernavaca, Mexico. He has made significant contributions to the field of biochemistry, particularly in the area of platelet aggregation inhibition. With a total of 3 patents, his work has implications for both medical and therapeutic applications.

Latest Patents

Possani's latest patents include innovative solutions such as a thrombin inhibitor derived from the saliva of protostomia. Another significant invention is a collagen-induced platelet aggregation inhibitor, which provides a protein that inhibits collagen-induced platelet aggregation. This protein is derived from Triatoma pallidipennis and is useful for inhibiting collagen-induced human platelet aggregation or for targeting cancer with metastatic tumor cells.

Career Highlights

Lourival Possani is associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals and biotechnology. His work at this organization has allowed him to focus on groundbreaking research that addresses critical health issues.

Collaborations

Possani has collaborated with esteemed colleagues such as Christiane Noeske-Jungblut and Wolf-Dieter Schleuning. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Lourival Possani's contributions to the field of biochemistry, particularly in platelet aggregation inhibition, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.